miR-17–5p/STAT3/H19: A novel regulatory axis tuning ULBP2 expression in young breast cancer patients.

MLA

Abdelhamid, A. M., et al. “MiR-17–5p/STAT3/H19: A Novel Regulatory Axis Tuning ULBP2 Expression in Young Breast Cancer Patients.” Pathology - Research & Practice, vol. 263, Nov. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.prp.2024.155638.

APA

Abdelhamid, A. M., Zeinelabdeen, Y., Manie, T., Khallaf, E., Assal, R. A., & Youness, R. A. (2024). miR-17–5p/STAT3/H19: A novel regulatory axis tuning ULBP2 expression in young breast cancer patients. Pathology - Research & Practice, 263, N.PAG. https://doi.org/10.1016/j.prp.2024.155638

Chicago

Abdelhamid, A.M., Y. Zeinelabdeen, T. Manie, E. Khallaf, R.A. Assal, and R.A. Youness. 2024. “MiR-17–5p/STAT3/H19: A Novel Regulatory Axis Tuning ULBP2 Expression in Young Breast Cancer Patients.” Pathology - Research & Practice 263 (November): N.PAG. doi:10.1016/j.prp.2024.155638.